Kolmar BNH Co., Ltd. (200130.KQ)
KRW 12520.0
(3.3%)
KRW 12520.0
(3.3%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 19.7 Billion KRW | -51.35% |
| 2022 | 40.51 Billion KRW | -42.01% |
| 2021 | 69.86 Billion KRW | -13.19% |
| 2020 | 80.48 Billion KRW | 47.72% |
| 2019 | 54.48 Billion KRW | 12.68% |
| 2018 | 48.35 Billion KRW | 5.64% |
| 2017 | 45.77 Billion KRW | 54.07% |
| 2016 | 29.7 Billion KRW | 2528.83% |
| 2015 | 1.13 Billion KRW | 236.81% |
| 2014 | -825.99 Million KRW | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 5.34 Billion KRW | -21.38% |
| 2024 Q1 | 6.79 Billion KRW | 10962.11% |
| 2023 FY | 19.7 Billion KRW | -51.35% |
| 2023 Q1 | 6.49 Billion KRW | 95.56% |
| 2023 Q2 | 7.58 Billion KRW | 16.84% |
| 2023 Q3 | 5.69 Billion KRW | -24.84% |
| 2023 Q4 | -62.54 Million KRW | -101.1% |
| 2022 FY | 40.51 Billion KRW | -42.01% |
| 2022 Q4 | 3.31 Billion KRW | -65.89% |
| 2022 Q3 | 9.72 Billion KRW | -33.74% |
| 2022 Q2 | 14.68 Billion KRW | 14.87% |
| 2022 Q1 | 12.78 Billion KRW | -29.34% |
| 2021 Q2 | 17.24 Billion KRW | -19.21% |
| 2021 Q3 | 13.17 Billion KRW | -23.6% |
| 2021 FY | 69.86 Billion KRW | -13.19% |
| 2021 Q1 | 21.35 Billion KRW | 30.86% |
| 2021 Q4 | 18.09 Billion KRW | 37.28% |
| 2020 FY | 80.48 Billion KRW | 47.72% |
| 2020 Q4 | 16.31 Billion KRW | -10.29% |
| 2020 Q3 | 18.18 Billion KRW | -33.95% |
| 2020 Q2 | 27.53 Billion KRW | 49.24% |
| 2020 Q1 | 18.44 Billion KRW | 54.08% |
| 2019 Q2 | 15.48 Billion KRW | 15.88% |
| 2019 Q1 | 13.36 Billion KRW | -12.69% |
| 2019 FY | 54.48 Billion KRW | 12.68% |
| 2019 Q4 | 11.97 Billion KRW | -12.33% |
| 2019 Q3 | 13.65 Billion KRW | -11.81% |
| 2018 Q2 | 10.56 Billion KRW | 1.32% |
| 2018 Q1 | 10.42 Billion KRW | 30.71% |
| 2018 Q3 | 12.04 Billion KRW | 14.03% |
| 2018 FY | 48.35 Billion KRW | 5.64% |
| 2018 Q4 | 15.3 Billion KRW | 27.03% |
| 2017 FY | 45.77 Billion KRW | 54.07% |
| 2017 Q2 | 19.27 Billion KRW | 119.86% |
| 2017 Q1 | 8.76 Billion KRW | 70.92% |
| 2017 Q4 | 7.97 Billion KRW | -18.21% |
| 2017 Q3 | 9.75 Billion KRW | -49.38% |
| 2016 Q2 | 8.26 Billion KRW | 3.72% |
| 2016 FY | 29.7 Billion KRW | 2528.83% |
| 2016 Q4 | 5.12 Billion KRW | -38.51% |
| 2016 Q3 | 8.34 Billion KRW | 0.88% |
| 2016 Q1 | 7.97 Billion KRW | 80.73% |
| 2015 Q4 | 4.41 Billion KRW | -45.94% |
| 2015 Q3 | 8.15 Billion KRW | 9.53% |
| 2015 Q2 | 7.44 Billion KRW | 139.44% |
| 2015 Q1 | -18.88 Billion KRW | 0.0% |
| 2015 FY | 1.13 Billion KRW | 236.81% |
| 2014 FY | -825.99 Million KRW | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| NeoPharm CO., LTD. | 23.21 Billion KRW | 15.091% |